Search Cancer Clinical Trials

Mass General Cancer Center offers patients access to a wide variety of clinical trials of promising new therapies. Use the search tool to find open protocols for your type of cancer.
Search by condition
Search By:
25 results
  • Ovarian Cancer

24-069          Phase II

FONTANA: A Modular Phase I/IIa, Open-label, Multi-center Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Ascending Doses of AZD5335 Monotherapy and in Combination with Anti-cancer Agents in Participants with Solid Tumors

  • Kidney Cancer, Ovarian Cancer, Melanoma

22-062          Phase II

IL Believe: A Phase 1/2, Open-label, Dose Escalation and Dose Expansion Study to Investigate the Safety and Tolerability of TransCon IL-2 ß/¿ Alone or in Combination with Pembrolizumab or Standard of Care Chemotherapy in Participants Aged 18 Years or Older with Locally Advanced or Metastatic Solid Tumor Malignancies

  • Ovarian Cancer

20-450          Phase II

Ovarian Cancer Detection By Uterine Lavage DNA And Serum Proteins: A Phase 2 Biomarker Study

  • Ovarian Cancer

24-566          Phase II

Phase 1/2 Study of PARG Inhibitor ETX-19477 in Patients with Advanced Solid Malignancies

  • Uterine Cancer, Ovarian Cancer

20-405          Phase II

Phase 1/2 study of REGN5668 (MUC16 X CD28, A COSTIMULATORY BISPECFIC) administered in combination with cemiplimab or REGN4018 (MUC16 X CD3)

Showing 21 - 25 of 25 results